PIK3CA and breast cancer: In addition, plasma ctDNA captures tumor heterogeneity and effectively reflects DNA shed from multiple metastatic sites.884 The NCCN Guidelines for Breast Cancer (version 4.2020) recommend the use of ctDNA analysis for the evaluation of PIK3CA mutations in breast cancer.884,885